GTY Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick SGMO Q1 2026 Earnings Gene Therapy Focus Drives Stock Higher Despite Deep EPS Miss PROV Q1 2026 Earnings EPS Misses Estimates Despite Modest Share Price Gain CARE Q1 2026 Earnings EPS Misses Estimates by Over 85 as Stock Rises Innoviz Technologies Q1 2026 Earnings Wider Loss Than Expected Yet Stock Gains enGene Holdings ENGN Q1 2026 Earnings Narrower Loss Than Expected Despite No Revenue